EMG
DGX icon

Ellington Management Group’s Quest Diagnostics DGX Stock Holding History

Ellington Management Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,300
Closed -$717K – 702
2017
Q1 		$717K Buy
7,300
+1,500
+26% +$143K 0.02% 190
2016
Q4 		$533K Buy
+5,800
New +$500K 0.08% 206

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ellington Management Group's DGX Position: Q2 2017 in Review

Ellington Management Group sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 7,300 shares — an estimated $717K sold.

Ellington Management Group first reported a position in DGX in Q4 2016 and held it in 2 quarters. The position peaked at $717K in Q1 2017. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Ellington Management Group reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Ellington Management Group sold 7,300 Quest Diagnostics shares in Q2 2017, an estimated $717K.
  • Ellington Management Group first reported a position in Quest Diagnostics in Q4 2016 and held it in 2 quarters.
  • Ellington Management Group's Quest Diagnostics position peaked at $717K in Q1 2017.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Ellington Management Group's 13F filing for Q2 2017, filed 14 Aug 2017.